These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10428919)

  • 1. Safety and tolerability of fluconazole in children.
    Novelli V; Holzel H
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1955-60. PubMed ID: 10428919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Meta-analysis of the efficacy and safety of fluconazole in prophylaxis of fungal infection in very low birth weight infants].
    Zhang JP; Chen C
    Zhonghua Er Ke Za Zhi; 2009 Dec; 47(12):891-7. PubMed ID: 20193139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicentre study of fluconazole versus oral polyenes in the prevention of fungal infection in children with hematological or oncological malignancies. Multicentre Study Group.
    Ninane J
    Eur J Clin Microbiol Infect Dis; 1994 Apr; 13(4):330-7. PubMed ID: 7794307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial.
    Winston DJ; Maziarz RT; Chandrasekar PH; Lazarus HM; Goldman M; Blumer JL; Leitz GJ; Territo MC
    Ann Intern Med; 2003 May; 138(9):705-13. PubMed ID: 12729424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of fluconazole in the treatment of systemic fungal infections in pediatric patients. Multicentre Study Group.
    Presterl E; Graninger W
    Eur J Clin Microbiol Infect Dis; 1994 Apr; 13(4):347-51. PubMed ID: 8070445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Why might micafungin be the drug of choice in pediatric patients?].
    Ramos Amador JT; Prieto Tato L; Guillén Martín S
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 2():23-8. PubMed ID: 21420573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole versus fluconazole in allogeneic blood hematopoietic stem cell transplantation recipients-A retrospective analysis of a single medical center in Taiwan.
    Wang CH; Kan LP; Lin HA; Chang FY; Wang NC; Lin TY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC
    J Microbiol Immunol Infect; 2016 Aug; 49(4):531-8. PubMed ID: 25440977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia.
    Döring M; Eikemeier M; Cabanillas Stanchi KM; Hartmann U; Ebinger M; Schwarze CP; Schulz A; Handgretinger R; Müller I
    Eur J Clin Microbiol Infect Dis; 2015 Jun; 34(6):1189-200. PubMed ID: 25680318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oropharyngeal candidiasis in immunocompromised children: a randomized, multicenter study of orally administered fluconazole suspension versus nystatin. The Multicenter Fluconazole Study Group.
    Flynn PM; Cunningham CK; Kerkering T; San Jorge AR; Peters VB; Pitel PA; Harris J; Gilbert G; Castagnaro L; Robinson P
    J Pediatr; 1995 Aug; 127(2):322-8. PubMed ID: 7636666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluconazole prophylaxis in preterm infants: a multicenter case-controlled analysis of efficacy and safety.
    Kaufman DA; Morris A; Gurka MJ; Kapik B; Hetherington S
    Early Hum Dev; 2014 Mar; 90 Suppl 1():S87-90. PubMed ID: 24709470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses.
    Debruyne D
    Clin Pharmacokinet; 1997 Jul; 33(1):52-77. PubMed ID: 9250423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluconazole treatment of neonates and infants with severe fungal infections.
    Gürpinar AN; Balkan E; Kiliç N; Kiriştioğlu I; Avşar I; Doğruyol H
    J Int Med Res; 1997; 25(4):214-8. PubMed ID: 9283996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled trial of oral itraconazole solution versus intravenous/oral fluconazole for prevention of fungal infections in liver transplant recipients.
    Winston DJ; Busuttil RW
    Transplantation; 2002 Sep; 74(5):688-95. PubMed ID: 12352887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluconazole treatment of children with severe fungal infections not treatable with conventional agents.
    Fasano C; O'Keeffe J; Gibbs D
    Eur J Clin Microbiol Infect Dis; 1994 Apr; 13(4):344-7. PubMed ID: 8070444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluconazole population pharmacokinetics and dosing for prevention and treatment of invasive Candidiasis in children supported with extracorporeal membrane oxygenation.
    Watt KM; Gonzalez D; Benjamin DK; Brouwer KL; Wade KC; Capparelli E; Barrett J; Cohen-Wolkowiez M
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3935-43. PubMed ID: 25896706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients.
    Ally R; Schürmann D; Kreisel W; Carosi G; Aguirrebengoa K; Dupont B; Hodges M; Troke P; Romero AJ;
    Clin Infect Dis; 2001 Nov; 33(9):1447-54. PubMed ID: 11577374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial.
    Viscoli C; Castagnola E; Van Lint MT; Moroni C; Garaventa A; Rossi MR; Fanci R; Menichetti F; Caselli D; Giacchino M; Congiu M
    Eur J Cancer; 1996 May; 32A(5):814-20. PubMed ID: 9081359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients.
    Goa KL; Barradell LB
    Drugs; 1995 Oct; 50(4):658-90. PubMed ID: 8536553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of Laboratory Test Result Monitoring in Patients Taking Oral Terbinafine or Griseofulvin for Dermatophyte Infections.
    Stolmeier DA; Stratman HB; McIntee TJ; Stratman EJ
    JAMA Dermatol; 2018 Dec; 154(12):1409-1416. PubMed ID: 30347032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and tolerability of nevirapine-based antiretroviral therapy in HIV-infected patients receiving fluconazole for cryptococcal prophylaxis: a retrospective cohort study.
    Manosuthi W; Chumpathat N; Chaovavanich A; Sungkanuparph S
    BMC Infect Dis; 2005 Aug; 5():67. PubMed ID: 16120209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.